Login / Signup

Pathophysiological and Clinical Potential of Human Microbiome: Microbe-based Therapeutic Insights.

Somali SanyalKumud NigamSukriti SinghPuja LohaniManish Dwivedi
Published in: Current pharmaceutical biotechnology (2024)
The human microbiota represents the community and diverse population of microbes within the human body, which comprises approximately 100 trillion micro-organisms. They exist in the human gastrointestinal tract and various other organs and are now considered virtual body organs. It is mainly represented by bacteria but also includes viruses, fungi, and protozoa. Although there is a heritable component to the gut microbiota, environmental factors related to diet, drugs, and anthropometry determine the composition of the microbiota. Besides the gastrointestinal tract, the human body also harbours microbial communities in the skin, oral and nasal cavities, and reproductive tract. The current review demonstrates the role of gut microbiota and its involvement in processing food, drugs, and immune responses. The discussion focuses on the implications of human microbiota in developing several diseases, such as gastrointestinal infections, metabolic disorders, malignancies, etc., through symbiotic relationships. The microbial population may vary depending on the pathophysiological condition of an individual and thus may be exploited as a therapeutic and clinical player. Further, we need a more thorough investigation to establish the correlation between microbes and pathophysiology in humans and propose them as potential therapeutic targets.
Keyphrases
  • endothelial cells
  • induced pluripotent stem cells
  • immune response
  • pluripotent stem cells
  • healthcare
  • mental health
  • multidrug resistant
  • toll like receptor